Partial
Partially Aligned
Patient Risk:
Medium
Summary
The evaluation largely maps claims to labeled safety information (tendon injury, neuropathy, CNS effects, QT prolongation, interactions, dosing, administration, and special populations). However, there are significant omissions (notably explicit boxed warnings, contraindications, and detailed pediatric safety wording) and some guidance (e.g., caffeine interactions) that is not supported by the label. Overall alignment is partial rather than comprehensive.
Category Scores
MonitoringRecommendations
60
Accurate Statements
Levofloxacin is a synthetic antibiotic (a fluoroquinolone).
12.1
Levofloxacin is not a traditional Chinese patent medicine.
17.3
Levofloxacin can cause tendonitis.
5.1
Levofloxacin can cause tendon rupture.
5.1
Levofloxacin can cause peripheral neuropathy.
5.8
Levofloxacin can cause confusion.
5.6
Levofloxacin can cause tremor.
5.6
Levofloxacin can cause seizures.
5.6
Levofloxacin can cause QT interval prolongation.
5.9
The risks are higher in older adults.
8.5
The risks are higher in people with kidney disease.
8.5
The risks are higher in those on certain other meds.
7
Levofloxacin should be avoided in pregnancy or breastfeeding.
8.1, 8.3
Levofloxacin is usually not given to children unless for specific serious infections.
2.2, 8.4
Levofloxacin commonly causes photosensitivity.
5.12
Antacids reduce absorption of levofloxacin if taken within 2 hours before or after a dose.
2.4
Calcium-containing mineral supplements reduce absorption if taken within 2 hours before or after a dose.
2.4
Magnesium-containing mineral supplements reduce absorption if taken within 2 hours before or after a dose.
2.4
Aluminum-containing mineral supplements reduce absorption if taken within 2 hours before or after a dose.
2.4
Iron-containing mineral supplements reduce absorption if taken within 2 hours before or after a dose.
2.4
Zinc-containing mineral supplements reduce absorption if taken within 2 hours before or after a dose.
2.4
Sucralfate reduces absorption of levofloxacin if taken within 2 hours before or after a dose.
2.4
When combined with a drug that can prolong the QT interval, there could be additive risk.
5.9
If you have a heart rhythm problem or are on other QT-prolonging meds, caution is warranted.
5.9, 8.5
Levofloxacin is mainly excreted by the kidneys, so kidney function matters.
8.5
Chinese patent medicines vary in quality and composition.
17.3
Tell your clinician about all medicines you’re taking, including all Chinese patent medicines, dosages, and timing.
17.3
If starting a new patent medicine, ask your provider whether any dose timing adjustments are needed.
17.3
If you notice new symptoms (palpitations, fainting, severe diarrhea, bloody stools, severe allergic reactions), seek care promptly.
17.3
Unsupported Statements
Caffeine may exacerbate CNS effects in sensitive people.
Not described in the provided label sections.
Moderate your caffeine intake if you notice jitteriness or sleep issues.
Not described in the provided label sections.
Some herbs or herbs can affect heart rhythm.
Not described in the provided label sections.
A few herbs can affect liver or kidney function or interact with other drugs.
Not described in the provided label sections.
Contaminants or mislabeled ingredients can pose added risks.
Not described in the provided label sections.
Some herbs or minerals in patent formulas can interfere with absorption of levofloxacin if taken too close together.
While absorption interactions are described, the exact wording and scope about 'herbs or minerals' and 'patent formulas' may not be explicitly stated as such in the label beyond 17.3; treated as not directly labeled verbatim.
Some herbs can affect liver or kidney function or interact with other drugs.
Not described in the provided label sections.
Contradictions
Important Omissions
Explicit boxed warnings for tendon injury, peripheral neuropathy, CNS effects, and QT prolongation.
Importance:
High
Contraindications language (e.g., known hypersensitivity to levofloxacin or quinolones) clearly stated as contraindications.
Importance:
High
Explicit pediatric safety wording about cartilage toxicity/arthropathy risk and age-specific indications.
Importance:
High
Explicit renal dosing adjustment guidance across different levels of impairment beyond general statements.
Importance:
High
Safety Assessment
Potential Patient Risk:
Medium
Label-supported risks include tendon disorders, neuropathy, CNS effects, and QT prolongation, with increased risk in older adults and renal impairment. However, absence of explicit boxed warnings and contraindications in the assessment reduces perceived safety completeness.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Partially Aligned
Primary Issue
Missing explicit boxed warnings and contraindications; incomplete coverage of pediatric safety and renal dosing details.
Suggested Improvement
Incorporate explicit Boxed Warning language for tendon rupture/neurpathy/CNS effects/QT prolongation; add explicit contraindications; clarify pediatric safety/arthropathy risks and supported indications for children; provide explicit renal dosing guidance and monitoring language; ensure caffeine and herbal interaction guidance is clearly supported or removed based on labeling.